Fund shareholders of United Therapeutics Corp
ISIN US91307C1027 · United States · LEI 5299005C4HZL4UWROC14
- Fund shareholders
- 696
- Of which ETFs
- 190 506 other funds
- Value held
- 8.7B $ 2.6B SEK · 1.5M €
- Share of capital
- 36.3 % of 42.9M shares on Jul 29, 2026
696 funds hold this company. This table lists the 693 that declare it in a regulatory filing. The other 3 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF iShares Trust | 1,425,491 | 845.3M $ | 0.80 % | 3.32 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,392,532 | 825.7M $ | 0.04 % | 3.25 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1,010,571 | 599.2M $ | 0.36 % | 2.36 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 822,896 | 470.2M $ | 1.28 % | 1.92 % | as of Apr 30, 2026 ↗ |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 643,525 | 381.6M $ | 0.63 % | 1.50 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 480,606 | 285M $ | 0.35 % | 1.12 % | as of Mar 31, 2026 ↗ |
| Invesco S&P MidCap Quality ETF Invesco Exchange-Traded Fund Trust | 361,146 | 206.3M $ | 3.98 % | 0.84 % | as of Apr 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 315,509 | 187.1M $ | 2.30 % | 0.74 % | as of Mar 31, 2026 ↗ |
| iShares S&P Mid-Cap 400 Growth ETF iShares Trust | 261,785 | 155.2M $ | 1.57 % | 0.61 % | as of Mar 31, 2026 ↗ |
| FULLERTHALER BEHAVIORAL SMALL CAP EQUITY Capitol Series Trust | 261,071 | 154.8M $ | 1.38 % | 0.61 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 246,943 | 146.4M $ | 1.34 % | 0.58 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 225,190 | 113.5M $ | 0.28 % | 0.53 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF SPDR SERIES TRUST | 210,359 | 124.7M $ | 0.80 % | 0.49 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 192,835 | 97.2M $ | 0.11 % | 0.45 % | as of Feb 28, 2026 ↗ |
| VANGUARD U.S. GROWTH FUND VANGUARD WORLD FUND | 186,211 | 93.8M $ | 0.21 % | 0.43 % | as of Feb 28, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 166,849 | 98.9M $ | 4.36 % | 0.39 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 162,241 | 96.2M $ | 0.20 % | 0.38 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 157,079 | 89.7M $ | 0.18 % | 0.37 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 155,530 | 92.2M $ | 1.24 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Franklin Dynatech Fund Franklin Custodian Funds | 150,000 | 88.9M $ | 0.36 % | 0.35 % | as of Mar 31, 2026 ↗ |
| Fidelity SAI U.S. Quality Index Fund Fidelity Salem Street Trust | 131,501 | 75.1M $ | 0.26 % | 0.31 % | as of Apr 30, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 130,512 | 65.8M $ | 0.03 % | 0.30 % | as of Feb 28, 2026 ↗ |
| Pacer US Cash Cows 100 ETF Pacer Funds Trust | 130,190 | 74.4M $ | 0.41 % | 0.30 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 129,071 | 65M $ | 0.32 % | 0.30 % | as of Feb 28, 2026 ↗ |
| Swedbank Robur Aktiefond Pension Swedbank Robur Fonder AB | 118,674 | 670.4M SEK | 0.63 % | 0.28 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 116,721 | 69.2M $ | 1.33 % | 0.27 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 116,323 | 58.6M $ | 0.43 % | 0.27 % | as of Feb 28, 2026 ↗ |
| iShares Russell 1000 Value ETF iShares Trust | 97,116 | 57.6M $ | 0.08 % | 0.23 % | as of Mar 31, 2026 ↗ |
| Pacer US Large Cap Cash Cows Growth Leaders ETF Pacer Funds Trust | 95,745 | 54.7M $ | 2.52 % | 0.22 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Fundamental Equity Fund LORD ABBETT SECURITIES TRUST | 91,588 | 52.3M $ | 2.37 % | 0.21 % | as of Apr 30, 2026 ↗ |
| HARTFORD CORE EQUITY FUND HARTFORD MUTUAL FUNDS, INC | 90,258 | 51.6M $ | 0.45 % | 0.21 % | as of Apr 30, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 88,135 | 497.9M SEK | 0.04 % | 0.21 % | as of Mar 31, 2026 ↗ |
| iShares MSCI USA Min Vol Factor ETF iShares Trust | 85,283 | 48.7M $ | 0.21 % | 0.20 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 80,448 | 40.5M $ | 0.03 % | 0.19 % | as of Feb 28, 2026 ↗ |
| iShares MSCI USA Quality Factor ETF iShares Trust | 77,857 | 44.5M $ | 0.09 % | 0.18 % | as of Apr 30, 2026 ↗ |
| Janus Henderson Research Fund JANUS INVESTMENT FUND | 76,641 | 45.4M $ | 0.18 % | 0.18 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Transfer 70 Swedbank Robur Fonder AB | 71,315 | 402.8M SEK | 0.41 % | 0.17 % | as of Mar 31, 2026 ↗ |
| VANGUARD S&P MID-CAP 400 INDEX FUND VANGUARD ADMIRAL FUNDS | 65,534 | 33M $ | 0.63 % | 0.15 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S & P 400(TM) Mid Cap Growth ETF SPDR SERIES TRUST | 65,450 | 38.8M $ | 1.57 % | 0.15 % | as of Mar 31, 2026 ↗ |
| VIP Mid Cap Portfolio Variable Insurance Products Fund III | 65,400 | 38.8M $ | 0.49 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 63,937 | 32.2M $ | 0.03 % | 0.15 % | as of Feb 28, 2026 ↗ |
| THE U.S. LARGE CAP VALUE SERIES DFA INVESTMENT TRUST CO | 62,442 | 35.7M $ | 0.12 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 62,218 | 35.5M $ | 0.08 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Fidelity Mid-Cap Stock Fund Fidelity Concord Street Trust | 61,483 | 35.1M $ | 0.40 % | 0.14 % | as of Apr 30, 2026 ↗ |
| iShares Russell Mid-Cap Value ETF iShares Trust | 61,017 | 36.2M $ | 0.26 % | 0.14 % | as of Mar 31, 2026 ↗ |
| LORD ABBETT MID CAP STOCK FUND INC LORD ABBETT MID CAP STOCK FUND INC | 56,726 | 33.6M $ | 3.10 % | 0.13 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 56,215 | 32.1M $ | 0.08 % | 0.13 % | as of Apr 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 55,689 | 28.1M $ | 0.43 % | 0.13 % | as of Feb 27, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 54,127 | 32.1M $ | 0.04 % | 0.13 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 53,489 | 30.6M $ | 0.08 % | 0.12 % | as of Apr 30, 2026 ↗ |
| First Trust Growth Strength ETF First Trust Exchange-Traded Fund | 53,047 | 31.5M $ | 2.71 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 52,989 | 31.4M $ | 0.02 % | 0.12 % | as of Mar 31, 2026 ↗ |
| THRIVENT MID CAP STOCK FUND Thrivent Mutual Funds | 52,500 | 30M $ | 1.00 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Nuveen Mid Cap Value Fund TIAA-CREF Funds | 50,920 | 29.1M $ | 1.74 % | 0.12 % | as of Apr 30, 2026 ↗ |
| GuidePath Tactical Allocation Fund GPS Funds II | 49,592 | 29.4M $ | 4.04 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Transfer 80 Swedbank Robur Fonder AB | 46,482 | 262.6M SEK | 0.27 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 44,593 | 22.5M $ | 0.42 % | 0.10 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 43,954 | 22.1M $ | 0.03 % | 0.10 % | as of Feb 28, 2026 ↗ |
| JNL Mid Cap Index Fund JNL Series Trust | 43,446 | 25.8M $ | 0.79 % | 0.10 % | as of Mar 31, 2026 ↗ |
| AQR Large Cap Defensive Style Fund AQR Funds | 40,465 | 24M $ | 1.77 % | 0.09 % | as of Mar 31, 2026 ↗ |
| AQR Long-Short Equity Fund AQR Funds | 40,453 | 24M $ | 0.30 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Lord Abbett Value Opportunities Fund LORD ABBETT SECURITIES TRUST | 40,305 | 23M $ | 2.03 % | 0.09 % | as of Apr 30, 2026 ↗ |
| VANGUARD S&P MID-CAP 400 GROWTH INDEX FUND VANGUARD ADMIRAL FUNDS | 39,277 | 19.8M $ | 1.21 % | 0.09 % | as of Feb 28, 2026 ↗ |
| iShares MSCI USA Value Factor ETF iShares Trust | 38,675 | 22.1M $ | 0.18 % | 0.09 % | as of Apr 30, 2026 ↗ |
| JPMorgan U.S. Quality Factor ETF J.P. Morgan Exchange-Traded Fund Trust | 38,570 | 22M $ | 0.30 % | 0.09 % | as of Apr 30, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 36,458 | 21.6M $ | 0.02 % | 0.09 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P U.S. Growth ETF iShares Trust | 36,396 | 21.6M $ | 0.08 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 36,086 | 20.6M $ | 0.04 % | 0.08 % | as of Apr 30, 2026 ↗ |
| EQ/Mid Cap Index Portfolio EQ Advisors Trust | 35,293 | 20.9M $ | 0.79 % | 0.08 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 35,135 | 20.1M $ | 0.02 % | 0.08 % | as of Apr 30, 2026 ↗ |
| U.S. Growth Fund John Hancock Funds III | 34,856 | 20.7M $ | 0.73 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Simplify Health Care ETF Simplify Exchange Traded Funds | 34,623 | 20.5M $ | 8.77 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Poplar Forest Partners Fund Advisors Series Trust | 34,400 | 20.4M $ | 6.12 % | 0.08 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small & Mid Cap Enhanced Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 33,476 | 19.9M $ | 0.83 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Mid Cap Index Fund VALIC Co I | 32,882 | 16.6M $ | 0.63 % | 0.08 % | as of Feb 28, 2026 ↗ |
| THRIVENT MID CAP STOCK PORTFOLIO Thrivent Series Fund, Inc. | 32,724 | 19.4M $ | 1.11 % | 0.08 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Small-Cap Equity Factor ETF iShares Trust | 32,420 | 18.5M $ | 0.51 % | 0.08 % | as of Apr 30, 2026 ↗ |
| John Hancock Multifactor Mid Cap ETF John Hancock Exchange-Traded Fund Trust | 32,365 | 19.2M $ | 0.39 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Swedbank Robur Transfer 60 Swedbank Robur Fonder AB | 31,793 | 179.6M SEK | 0.40 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Columbia Mid Cap Index Fund COLUMBIA FUNDS SERIES TRUST | 31,750 | 16M $ | 0.62 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Frontier Mid Cap Growth Portfolio Brighthouse Funds Trust II | 31,276 | 18.5M $ | 1.94 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Marketwide Value ETF Dimensional ETF Trust | 31,015 | 17.7M $ | 0.12 % | 0.07 % | as of Apr 30, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 30,943 | 18.3M $ | 0.07 % | 0.07 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS | 30,921 | 18.3M $ | 0.18 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Franklin U.S. Mid Cap Multifactor Index ETF Franklin Templeton ETF Trust | 30,400 | 18M $ | 1.08 % | 0.07 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 30,201 | 17.9M $ | 0.04 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Allspring Large Cap Core Fund ALLSPRING FUNDS TRUST | 29,732 | 17M $ | 2.14 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 28,243 | 16.7M $ | 1.05 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Horizon Multi-Factor Small/Mid Cap Fund Horizon Funds | 27,617 | 13.9M $ | 2.04 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 27,212 | 15.5M $ | 6.28 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Mid Cap Index Fund Northern Funds | 27,065 | 16M $ | 0.78 % | 0.06 % | as of Mar 31, 2026 ↗ |
| HARTFORD DISCIPLINED EQUITY HLS FUND HARTFORD SERIES FUND INC | 26,500 | 15.7M $ | 0.57 % | 0.06 % | as of Mar 31, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 25,529 | 14.6M $ | 1.67 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 25,281 | 14.4M $ | 0.04 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 25,213 | 12.7M $ | 0.06 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 24,987 | 12.6M $ | 0.03 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 24,969 | 14.8M $ | 0.04 % | 0.06 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 24,656 | 14.6M $ | 0.02 % | 0.06 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 24,523 | 12.4M $ | 0.07 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 23,856 | 14.1M $ | 3.81 % | 0.06 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Health Care ETF Simplify Exchange Traded Funds | 8.77 % | as of Mar 31, 2026 ↗ |
| LIVE OAK HEALTH SCIENCES FUND Oak Associates Funds | 6.40 % | as of Apr 30, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 6.28 % | as of Apr 30, 2026 ↗ |
| Poplar Forest Partners Fund Advisors Series Trust | 6.12 % | as of Mar 31, 2026 ↗ |
| Saratoga Health & Biotechnology Fund SARATOGA ADVANTAGE TRUST | 5.04 % | as of Feb 28, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 4.65 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 4.40 % | as of Sep 30, 2025 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 4.36 % | as of Mar 31, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 4.35 % | as of Feb 28, 2026 ↗ |
| GuidePath Tactical Allocation Fund GPS Funds II | 4.04 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 648 | +27 | 15,103,792 | +6.3 % |
| 2026Q1 | 621 | +34 | 14,213,355 | -7.1 % |
| 2025Q4 | 587 | -19 | 15,292,879 | -7.8 % |
| 2025Q3 | 606 | -52 | 16,592,630 | -3.9 % |
| 2025Q2 | 658 | +7 | 17,273,954 | -2.2 % |
| 2025Q1 | 651 | -5 | 17,666,227 | +3.2 % |
| 2024Q4 | 656 | +45 | 17,123,856 | -0.6 % |
| 2024Q3 | 611 | +39 | 17,231,152 | +0.7 % |
| 2024Q2 | 572 | +25 | 17,112,073 | +4.0 % |
| 2024Q1 | 547 | +4 | 16,456,387 | -10.2 % |
| 2023Q4 | 543 | 18,334,597 |
Institutional managers
840 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 5,399,649 | 3.2B $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 2,630,000 | 1.6B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,264,247 | 1.3B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,843,963 | 1.1B $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,787,019 | 1.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,233,029 | 729.9M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 866,930 | 514M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 826,226 | 486.4M $ | as of Mar 31, 2026 |
| ASSETMARK, INC | 616,050 | 365.3M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 608,367 | 360.7M $ | as of Mar 31, 2026 |
| FMR LLC | 528,346 | 313.3M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 512,739 | 304M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 457,000 | 271M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 436,566 | 258.9M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 428,127 | 253.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 409,288 | 242.7M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 405,447 | 240.4K $ | as of Mar 31, 2026 |
| LSV ASSET MANAGEMENT | 398,665 | 236.4K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 360,643 | 213.9M $ | as of Mar 31, 2026 |
| Caisse de depot et placement du Quebec | 343,659 | 203.8M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 329,148 | 195.2M $ | as of Mar 31, 2026 |
| Swedbank AB | 327,122 | 194M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 309,220 | 183.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 300,481 | 178.2M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 300,204 | 178K $ | as of Mar 31, 2026 |
Declared shareholders of United Therapeutics Corp
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 5.19 % | 2,278,348 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of United Therapeutics Corp". https://titelia.com/en/stocks/united-therapeutics-corp-US91307C1027